LL-37
Human cathelicidin antimicrobial peptide: broad-spectrum antimicrobial and immune modulator.
- Typical dose
- 50 mcg – 500 mcg
- Frequency
- once daily
- Route
- Subcutaneous
- Half-life
- 5 hours
- Routes
- Subcutaneous
- Status
- Research chemical
Benefits
- Antimicrobial
- Anti-biofilm
- Wound healing
- Immune modulation
Dosing
A common research range for LL-37 is 50 mcg to 500 mcg once daily. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Reconstitution
A typical reconstitution for LL-37 is 5 mg of peptide in 2 mL of bacteriostatic water, giving roughly 2.5 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.
Half-life
LL-37 has an approximate half-life of 5 hours. Vial can display informational half-life estimates when supported data is available. These estimates are not measured blood concentrations or dosing instructions.
Storage
2-8°C post-reconstitution.
Reported side effects
- Injection site reactions
- Herxheimer-like reactions
Commonly stacked with
Track LL-37 with Vial
Vial logs every LL-37 dose, organizes your schedule, and offers reconstitution math and supported half-life estimates. Tracking records stay on your device. A Vial Pro subscription is required. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. LL-37 is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.